Highlights: Avecho has announced formal ethics approval of its pivotal Phase III clinical trial testing its oral CBD softgel capsule for insomnia. The study is the largest randomised, placebo controlled study being undertaken in Australia to support registration of cannabidiol as an over-the-counter medicine with the Therapeutic Goods Administration (TGA) The study has been purposefully designed to produce relevant clinical evidence, which is applicable to support product registration with key global regulatory bodies including the TGA, the FDA and the EMEA.
- Forums
- ASX - By Stock
- Ann: Trading Halt
Highlights: Avecho has announced formal ethics approval of its...
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVE (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.67M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.4¢ | $1.801K | 512.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
36 | 94441246 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 20308827 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
36 | 94441246 | 0.003 |
21 | 67185176 | 0.002 |
10 | 14500009 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 20308827 | 11 |
0.005 | 56913059 | 27 |
0.006 | 23195872 | 17 |
0.007 | 15212721 | 9 |
0.008 | 5858888 | 5 |
Last trade - 15.46pm 06/05/2024 (20 minute delay) ? |
Featured News
AVE (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online